Covalon Technologies Ltd.COV.V

Health Care · Health Care Equipment & Services · TSX-V · Canada · covalon.com

Covalon Technologies Ltd. is a Canadian medical device company that researches, develops, manufactures, and markets products for infection management, advanced wound care, and surgical procedures. The company offers antimicrobial dressings, IV dressings, perioperative dressings, vascular access line guards, and wound dressings under brands including ColActive, CovaWound, IV Clear, SurgiClear, and VALGuard. Its products are sold directly and through distributors in the United States, Canada, the Middle East, Latin America, and Asia.

Key ratios

Operating cash flow growth

126.0%TTM

2025 -34.1%

EPS growth

-80.8%TTM

2025 -35.0%

FCF / Sales

21.3%TTM

2025 5.0%2024 10.2%2023 -13.8%

Net margin

3.1%TTM

2025 6.3%2024 8.6%2023 -16.8%

ROA

0.9%TTM

2025 3.3%2024 4.7%2023 -10.2%

ROE

3.4%TTM

2025 7.1%2024 11.5%2023 -20.7%

Revenue growth

-9.0%TTM

2025 5.3%2024 17.2%2023 46.6%

Recent news

Covalon Reports 2026 Second Quarter Results 2026-05-21 · Covalon IR Covalon Reports on 2026 First Quarter Results and Recent Achievements and Highlights 2026-02-25 · Covalon IR

Track COV.V in your journal

Save it to a watchlist, run a reverse DCF, and keep your notes on the company in one place. Free to start.

Create a free account

Figures are sourced from third parties and shown for research only. They may be delayed or incomplete, and nothing on this page is investment advice or a recommendation to buy or sell. Read the full disclaimer